Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Immunotherapy|October 21, 2021
Targeting the tumor microenvironment of Ewing sarcomaErin Morales, Michael Olson, Fiorella Iglesias, et al.Journal for Immunotherapy of Cancer|December 9, 2020
Role of immunotherapy in Ewing sarcomaErin Morales, Michael Olson, Fiorella Iglesias, et al.International Journal of Cancer|July 16, 2025
Rapid COJEC without myeloablative therapy for high-risk neuroblastomaBrian H Kushner, Ellen M Basu, Fiorella Iglesias Cardenas, et al.Journal of Pediatric Hematology/Oncology|January 15, 2021
Two Clonally Distinct B-Cell Lymphomas Reveal the Diagnosis of XLP1 in a Male Child and His Asymptomatic Male Relatives: Case Report and Review of the LiteratureFiorella Iglesias Cardenas, Archana M Agarwal, Jennie Vagher, et al.JCO Precision Oncology|August 10, 2023
Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in AdultsJessica Stiefel, Brian H Kushner, Stephen S Roberts, et al.Pediatric Blood & Cancer|June 24, 2025
Pulmonary Toxicity Associated With Concurrent Lorlatinib and Anti-GD2 Monoclonal Antibody Therapy in Patients With NeuroblastomaWei Wei, Maggie Eidson Fader, Brian H Kushner, et al.International Journal of Cancer|January 10, 2026
Naxitamab with novel scheduling and stepped-up dosing of GM-CSF plus vaccine, but no myeloablative therapy for patients with high-risk neuroblastoma in first complete remissionBrian H Kushner, Charlie White, Audrey Mauguen, et al.International Journal of Cancer|August 1, 2022
Immunotherapy with anti-GD2 monoclonal antibody in infants with high-risk neuroblastomaBrian H Kushner, Shakeel Modak, Kim Kramer, et al.Cancers|December 24, 2021
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk NeuroblastomaFiorella Iglesias Cardenas, Audrey Mauguen, Irene Y Cheung, et al.Pediatric Blood & Cancer|May 27, 2023
Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlationsBehtash G Nezami, Shakeel Modak, Fiorella Iglesias Cardenas, et al.Pageof 2